PCN73 Cost Effectiveness of Zoledronic Acid vs. Pamidronate or No therapy for the Treatment of Bone Metastases Secondary to Prostate Cancer
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1174
https://www.valueinhealthjournal.com/article/S1098-3015(11)02736-7/fulltext
Title :
PCN73 Cost Effectiveness of Zoledronic Acid vs. Pamidronate or No therapy for the Treatment of Bone Metastases Secondary to Prostate Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02736-7&doi=10.1016/j.jval.2011.08.1174
First page :
A447
Section Title :
Cancer
Open access? :
No
Section Order :
1131